Related Experiment Video

Updated: Apr 19, 2026

Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice
11:20

Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice

Published on: March 2, 2019

12.1K

[Pseudomonas aeruginosa elastase inhibits immune phagocytosis mediated by pulmonary surfactant protein A]

Yang Gao1, Zeng Wang1, Junqin Wang1

  • 1Department of Orthopaedics, Affiliated Hospital of Taishan Medical College, Taian 271000, China.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi = Chinese Journal of Cellular and Molecular Immunology
|December 8, 2014
PubMed
Abstract

Insights

Pseudomonas aeruginosa elastase degrades pulmonary surfactant protein A (SP-A), aiding bacterial survival. This elastase shields bacteria from phagocytic cells, highlighting a key virulence mechanism in P. aeruginosa infections.

Area of Science:

  • Microbiology
  • Immunology
  • Pulmonary Medicine

Background:

  • Pseudomonas aeruginosa (P.aeruginosa) is an opportunistic pathogen causing severe lung infections.
  • Pulmonary surfactant protein A (SP-A) plays a crucial role in innate immunity within the lungs.
  • The interaction between P.aeruginosa virulence factors and host immune components is not fully understood.

Purpose of the Study:

  • To investigate the relationship between P.aeruginosa elastase and SP-A.
  • To determine the role of P.aeruginosa elastase in SP-A degradation.
  • To assess the impact of SP-A on P.aeruginosa phagocytosis by macrophages.

Main Methods:

  • Infection of C3H mice with P.aeruginosa wild-type (PAO1) and a ΔlasB elastase mutant.
  • In vitro assessment of SP-A degradation by different P.aeruginosa strains using Western blotting.
  • In vitro phagocytosis assays using Raw264.7 macrophages and SP-A treated bacteria.

Main Results:

  • The P.aeruginosa ΔlasB mutant exhibited reduced virulence compared to the wild-type strain.
  • The ΔlasB mutant was unable to degrade SP-A in vitro.
  • SP-A enhanced the phagocytosis of the ΔlasB mutant more effectively than the wild-type P.aeruginosa.

Conclusions:

  • P.aeruginosa elastase contributes to bacterial virulence by degrading SP-A.
  • Degradation of SP-A by elastase protects P.aeruginosa from phagocytosis.
  • Targeting P.aeruginosa elastase may represent a therapeutic strategy against lung infections.

More Related Videos

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

12.0K
Quantifying the Modulation of Elastase Enzyme Activity Through Colorimetric Analysis04:30

Quantifying the Modulation of Elastase Enzyme Activity Through Colorimetric Analysis

Published on: January 17, 2025

2.5K

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
937
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
67.4K
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
16